Risedronate shown to be safe and effective in men with osteoporosis in a 2-year, double-blind, randomized, placebo-controlled, multicenter study

被引：0
|
作者：
Boonen, S.
Delmas, P. D.
Wenderoth, D.
Stoner, K. J.
Eusebio, R.
Orwoll, E. S.
机构：
[1] Katholieke Univ Leuven Hosp, Louvain, Belgium
[2] INSERM, Res Unit 403, F-69008 Lyon, France
[3] Procter & Gamble Pharmaceut, Schwalbach, Germany
[4] Procter & Gamble Pharmaceut, Mason, OH USA
[5] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
来源：
OSTEOPOROSIS INTERNATIONAL | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S230 / S231
页数：2
相关论文
共 50 条
  • [41] Vunakizumab in Patients with Active Psoriatic Arthritis: A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study
    Zou, Hejian
    Wan, Weiguo
    Xue, Yu
    Sun, Lingyun
    Zhang, Ning
    Chen, Haiying
    Shi, Xiaofei
    Liu, Shengyun
    Chen, Lin
    Ma, Xinmei
    Wei, Hua
    Jiang, Zhenyu
    Li, Xiaomei
    Fan, Hongtao
    Li, Hongbin
    Li, Jingyang
    Wu, Rui
    Shi, Guixiu
    Zhu, Jing
    Kong, Xiaodan
    Lu, Yuewu
    Cui, Xiaojing
    Zheng, Qianning
    Bai, Xiaoyan
    Dong, Guangchao
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 5240 - 5242
  • [42] Cerebrolysin and recovery after stroke (CARS 2): a randomized, placebo-controlled, double-blind, multicenter clinical study
    Guekht, A.
    Heiss, D.
    Gusev, E.
    Vester, J.
    Doppler, E.
    Muresanu, D.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E103 - E103
  • [43] Efficacy of acarbose in patients receiving dietary training and counselling - A 2-year placebo-controlled, double-blind study
    Hasche, H
    Mertes, G
    DIABETES, 1998, 47 : A90 - A90
  • [44] Cabergoline treatment in men with psychogenic erectile dysfunction: a randomized, double-blind, placebo-controlled study
    Nickel, M.
    Moleda, D.
    Loew, T.
    Rother, W.
    Gil, F. Pedrosa
    INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2007, 19 (01) : 104 - 107
  • [45] Cabergoline treatment in men with psychogenic erectile dysfunction: a randomized, double-blind, placebo-controlled study
    M Nickel
    D Moleda
    T Loew
    W Rother
    F Pedrosa Gil
    International Journal of Impotence Research, 2007, 19 : 104 - 107
  • [46] Effects of toremifene on hormones in men treated for 1 year in a double-blind, placebo-controlled study
    Stein, BS
    Zinner, N
    Israeli, RS
    Wake, R
    Mitchell, J
    Steiner, MS
    JOURNAL OF UROLOGY, 2005, 173 (04): : 272 - 272
  • [47] Randomized clinical trial: rikkunshito in the treatment of functional dyspepsiaa multicenter, double-blind, randomized, placebo-controlled study
    Suzuki, H.
    Matsuzaki, J.
    Fukushima, Y.
    Suzaki, F.
    Kasugai, K.
    Nishizawa, T.
    Naito, Y.
    Hayakawa, T.
    Kamiya, T.
    Andoh, T.
    Yoshida, H.
    Tokura, Y.
    Nagata, H.
    Kobayakawa, M.
    Mori, M.
    Kato, K.
    Hosoda, H.
    Takebayashi, T.
    Miura, S.
    Uemura, N.
    Joh, T.
    Hibi, T.
    Tack, J.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2014, 26 (07): : 950 - 961
  • [48] Double-blind randomized placebo-controlled trial of sibutramine
    Bray, GA
    Ryan, DH
    Gordon, D
    Heidingsfelder, S
    Cerise, F
    Wilson, K
    OBESITY RESEARCH, 1996, 4 (03): : 263 - 270
  • [49] Romosozumab in Postmenopausal Korean Women with Osteoporosis: A Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study
    Baek, Ki-Hyun
    Chung, Yoon-Sok
    Koh, Jung-Min
    Kim, In Joo
    Kim, Kyoung Min
    Min, Yong-Ki
    Park, Ki Deok
    Dinavahi, Rajani
    Maddox, Judy
    Yang, Wenjing
    Kim, Sooa
    Lee, Sang Jin
    Cho, Hyungjin
    Lim, Sung-Kil
    ENDOCRINOLOGY AND METABOLISM, 2021, 36 (01) : 60 - 69
  • [50] Tolerability of once-weekly alendronate in patients with osteoporosis: A randomized, double-blind, placebo-controlled study
    Greenspan, S
    Field-Munves, E
    Tonino, R
    Smith, M
    Petruschke, R
    Wang, LX
    Yates, J
    de Papp, AE
    Palmisano, J
    MAYO CLINIC PROCEEDINGS, 2002, 77 (10) : 1044 - 1052
12345